EPRXEupraxia Pharmaceuticals Inc.
$6.86+25% 1Y
$6.86
$5.3352 weeks$9.12
Latest close: below its 200-day averageOct 23, 2026what changed →
Is the business good?
How good a business is EPRX?
- Share count, year on year
- +18%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Revenue, trailing twelve months
- $0
- Free cash flow, trailing twelve months
- −$29M
- Net income, trailing twelve months
- −$39M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry